Aim. To develop the method for the quantitative determination of L-cystine in sublingual tablets Elthacin ® using the method of chemiluminescence inhibition in the H 2 L (luminol) – Н 2 О 2 – Нb (hemoglobin) system. Materials and methods. The study objects were the pure substance of L-cystine of pharmaceutical grade and sublingual tablets Elthacin ® produced by the Medical Scientific-Production Complex “Biotics Ltd” (Russia) containing 70 mg of glycine, L-glutaminic acid and L-cystine in their composition. The intensity of chemiluminescence was measured on the device with a FEU-84-A photoelectric multiplier using an IMT-0.5 measuring instrument of low currents and a quick-acting automatic potentiometer. Results and discussion. The method of the L-cystine quantitative determination in tablets based on the inhibition of chemiluminescence in the H 2 L – H 2 O 2 – Hb system has been developed. The calibration graph was linear over the concentration range from 7 to 70 μg · mL –1 . No interferences were observed in the presence of common components of the tablets, such as glycine and L-glutaminic acid. RSD = ± 2.35 %, (δ = + 1.13 %), LOD (3S) = 4 μg · mL –1 , LOQ (10S) = 13 μg · mL –1 for the sublingual tablets Elthacin ® . Conclusions. The method proposed is promising for further research on the subject of its application for the determination of L-cystine in drugs.
Read full abstract